Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo
- 24 September 2008
- journal article
- Published by Elsevier BV in Peptides
- Vol. 29 (12), 2243-2249
- https://doi.org/10.1016/j.peptides.2008.09.009
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineNeurology, 2008
- Adrenomedullin signaling is necessary for murine lymphatic vascular developmentJCI Insight, 2008
- VEGF-C Alters Barrier Function of Cultured Lymphatic Endothelial Cells Through a VEGFR-3-Dependent MechanismLymphatic Research and Biology, 2007
- Adrenomedullin and endothelial barrier functionThrombosis and Haemostasis, 2007
- Vascular Endothelial Growth Factor-A Mediates Ultraviolet B-Induced Impairment of Lymphatic Vessel FunctionThe American Journal of Pathology, 2006
- Adrenomedullin Improves the Blood–Brain Barrier Function Through the Expression of Claudin-5Cellular and Molecular Neurobiology, 2006
- Angiogenic role of adrenomedullin through activation of Akt, mitogen‐activated protein kinase, and focal adhesion kinase in endothelial cellsThe FASEB Journal, 2003
- Adrenomedullin, a Multifunctional Regulatory PeptideEndocrine Reviews, 2000
- Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistBritish Journal of Pharmacology, 2000
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993